Ovid Therapeutics Inc. Shares Outstanding (Cover Page)
Ovid Therapeutics Inc. (OVID) had Shares Outstanding (Cover Page) of 195.30 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 195.30M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 186.64M shares.
- 2026-03-16: Entity Common Stock, Shares Outstanding 131.87M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 71.21M shares.
| Period end | Entity Common Stock, Shares Outstanding | Entity Common Stock, Shares Outstanding as first filed |
|---|---|---|
| 2026-08-11 | 195.30M shares 10-Q · filed 2026-08-13 | |
| 2026-05-08 | 186.64M shares 10-Q · filed 2026-05-12 | |
| 2026-03-16 | 131.87M shares 10-K · filed 2026-03-18 | |
| 2025-11-07 | 71.21M shares 10-Q · filed 2025-11-12 | |
| 2025-08-08 | 71.11M shares 10-Q · filed 2025-08-13 | |
| 2025-05-09 | 71.11M shares 10-Q · filed 2025-05-13 | |
| 2025-03-07 | 71.11M shares 10-K/A · filed 2025-04-30 | 71.08M shares 10-K · filed 2025-03-11 |
| 2024-11-08 | 71.01M shares 10-Q · filed 2024-11-12 | |
| 2024-08-10 | 70.97M shares 10-Q · filed 2024-08-13 | |
| 2024-05-10 | 70.94M shares 10-Q · filed 2024-05-14 | |
| 2024-03-05 | 70.71M shares 10-K · filed 2024-03-08 | |
| 2023-10-31 | 70.68M shares 10-Q · filed 2023-11-03 | |
| 2023-08-01 | 70.60M shares 10-Q · filed 2023-08-04 | |
| 2023-05-02 | 70.52M shares 10-Q · filed 2023-05-05 | |
| 2023-03-10 | 70.49M shares 10-K · filed 2023-03-13 | |
| 2022-11-04 | 70.47M shares 10-Q · filed 2022-11-08 | |
| 2022-08-05 | 70.42M shares 10-Q · filed 2022-08-09 | |
| 2022-05-06 | 70.42M shares 10-Q · filed 2022-05-10 | |
| 2022-03-10 | 70.37M shares 10-K · filed 2022-03-15 | |
| 2021-11-08 | 68.09M shares 10-Q · filed 2021-11-10 | |
| 2021-08-06 | 67.93M shares 10-Q · filed 2021-08-16 | |
| 2021-05-05 | 67.81M shares 10-Q · filed 2021-05-13 | |
| 2021-03-08 | 65.75M shares 10-K · filed 2021-03-15 | |
| 2020-11-05 | 63.44M shares 10-Q · filed 2020-11-13 | |
| 2020-08-03 | 57.08M shares 10-Q · filed 2020-08-10 | |
| 2020-04-30 | 54.75M shares 10-Q · filed 2020-05-07 | |
| 2020-03-04 | 54.71M shares 10-K · filed 2020-03-11 | |
| 2019-11-06 | 47.82M shares 10-Q · filed 2019-11-08 | |
| 2019-07-30 | 38.69M shares 10-Q · filed 2019-08-07 | |
| 2019-04-29 | 38.69M shares 10-Q · filed 2019-05-07 | |
| 2019-02-28 | 38.65M shares 10-K · filed 2019-03-07 | |
| 2018-11-01 | 24.65M shares 10-Q · filed 2018-11-08 | |
| 2018-08-02 | 24.63M shares 10-Q · filed 2018-08-09 | |
| 2018-05-01 | 24.62M shares 10-Q · filed 2018-05-08 | |
| 2018-03-22 | 24.62M shares 10-K · filed 2018-03-29 | |
| 2017-11-08 | 24.60M shares 10-Q · filed 2017-11-09 | |
| 2017-08-10 | 24.60M shares 10-Q · filed 2017-08-10 | |
| 2017-06-13 | 24.60M shares 10-Q · filed 2017-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |